Rainbow BioSciences, LLC Explores New Funding for Expansion  
6/10/2013 10:09:07 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NOKOMIS, Fla.--(BUSINESS WIRE)--As Rainbow Coral Corp. (OTCBB: RBCC) pushes forward with its aggressive expansion strategy for 2013, the company is considering promising new funding opportunities in order to deliver cutting-edge innovations to the $232 billion personalized medicine market. RBCC is already poised for rapid growth this year. The company recently signed a joint venture agreement with TheraKine Ltd., the developer of a revolutionary, sustained-release drug delivery platform that could soon make local delivery of biologic agents and small molecules safer, more effective and more convenient than ever before, and is currently in negotiations to partner with an emerging innovator in the transdermal delivery sector, as well. Last month, RBCC’s joint venture partner, Nano3D BioSciences, announced a distribution agreement with St. Louis-based scientific products distributor MIDSCI to sell its revolutionary BioAssembler product line in the multi-billion-dollar U.S biotechnology market.

Help employers find you! Check out all the jobs and post your resume.